Metrovacesa Balance Sheet Health
Financial Health criteria checks 5/6
Metrovacesa has a total shareholder equity of €1.7B and total debt of €438.4M, which brings its debt-to-equity ratio to 26%. Its total assets and total liabilities are €2.5B and €847.4M respectively. Metrovacesa's EBIT is €65.2M making its interest coverage ratio 3.1. It has cash and short-term investments of €196.3M.
Key information
26.0%
Debt to equity ratio
€438.39m
Debt
| Interest coverage ratio | 3.1x |
| Cash | €196.30m |
| Equity | €1.69b |
| Total liabilities | €847.36m |
| Total assets | €2.53b |
Recent financial health updates
We Think Metrovacesa (BME:MVC) Can Stay On Top Of Its Debt
May 01
Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Nov 05These 4 Measures Indicate That Metrovacesa (BME:MVC) Is Using Debt Extensively
Jul 05Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Dec 02Would Metrovacesa (BME:MVC) Be Better Off With Less Debt?
Feb 16Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Oct 05Recent updates
We Think Metrovacesa (BME:MVC) Can Stay On Top Of Its Debt
May 01Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?
Mar 27A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)
Feb 12Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Nov 05These 4 Measures Indicate That Metrovacesa (BME:MVC) Is Using Debt Extensively
Jul 05Is Now An Opportune Moment To Examine Metrovacesa S.A. (BME:MVC)?
May 21Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)
Apr 19Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Dec 02Is It Too Late To Consider Buying Metrovacesa S.A. (BME:MVC)?
Sep 23Estimating The Intrinsic Value Of Metrovacesa S.A. (BME:MVC)
May 19Metrovacesa's (BME:MVC) Strong Earnings Are Of Good Quality
Mar 05Would Metrovacesa (BME:MVC) Be Better Off With Less Debt?
Feb 16Does Metrovacesa (BME:MVC) Have A Healthy Balance Sheet?
Oct 05Is Metrovacesa S.A. (BME:MVC) Worth €6.7 Based On Its Intrinsic Value?
Jul 02Is Metrovacesa (BME:MVC) Using Too Much Debt?
May 06Is Metrovacesa S.A. (BME:MVC) A Strong Dividend Stock?
Apr 06Metrovacesa (BME:MVC) Share Prices Have Dropped 51% In The Last Three Years
Mar 15Loss-Making Metrovacesa S.A. (BME:MVC) Set To Breakeven
Feb 16When Should You Buy Metrovacesa S.A. (BME:MVC)?
Jan 26
A Look At The Fair Value Of Metrovacesa S.A. (BME:MVC)
Jan 05If You Had Bought Metrovacesa's (BME:MVC) Shares A Year Ago You Would Be Down 24%
Dec 14Financial Position Analysis
Short Term Liabilities: MVC's short term assets (€2.1B) exceed its short term liabilities (€555.4M).
Long Term Liabilities: MVC's short term assets (€2.1B) exceed its long term liabilities (€292.0M).
Debt to Equity History and Analysis
Debt Level: MVC's net debt to equity ratio (14.4%) is considered satisfactory.
Reducing Debt: MVC's debt to equity ratio has increased from 3.4% to 26% over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: Whilst unprofitable MVC has sufficient cash runway for more than 3 years if it maintains its current positive free cash flow level.
Forecast Cash Runway: MVC is unprofitable but has sufficient cash runway for more than 3 years, due to free cash flow being positive and growing by 32.9% per year.